Evolent Health Inc. (NYSE:EVH)’s share price traded down 3% during mid-day trading on Friday . The stock traded as low as $25.86 and last traded at $25.90, with a volume of 297,197 shares changing hands. The stock had previously closed at $26.69.

Several equities analysts have recently issued reports on the stock. FBR & Co restated a “buy” rating on shares of Evolent Health in a report on Saturday, May 14th. Zacks Investment Research lowered Evolent Health from a “hold” rating to a “sell” rating in a research report on Wednesday, May 4th. Canaccord Genuity reiterated a “buy” rating and issued a $30.00 target price on shares of Evolent Health in a research report on Sunday, August 7th. Jefferies Group began coverage on Evolent Health in a research report on Tuesday, July 26th. They issued a “buy” rating and a $28.00 target price on the stock. Finally, Leerink Swann reiterated an “outperform” rating and issued a $20.00 target price on shares of Evolent Health in a research report on Sunday, July 17th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $22.50.

The company has a 50 day moving average of $22.29 and a 200-day moving average of $14.47. The company’s market cap is $1.10 billion.

Evolent Health (NYSE:EVH) last announced its quarterly earnings data on Thursday, August 4th. The company reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.04. The company earned $56.50 million during the quarter, compared to analysts’ expectations of $51.96 million. During the same quarter in the previous year, the business posted ($0.95) EPS. The business’s quarterly revenue was up 443.3% compared to the same quarter last year. Equities research analysts forecast that Evolent Health Inc. will post ($0.55) earnings per share for the current year.

An institutional investor recently raised its position in Evolent Health stock. Schroder Investment Management Group increased its stake in shares of Evolent Health Inc. (NYSE:EVH) by 120.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 355,922 shares of the company’s stock after buying an additional 194,222 shares during the period. Schroder Investment Management Group owned 0.60% of Evolent Health worth $4,310,000 at the end of the most recent quarter.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.